Showing metabocard for LysoPC(0:0/20:5(5Z,8Z,11Z,14Z,17Z)) (MMDBc0060138)
Microbial
Human
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2023-02-02 20:28:52 UTC | ||||||||||||
| Update Date | 2025-10-07 20:14:16 UTC | ||||||||||||
| Metabolite ID | MMDBc0060138 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | LysoPC(0:0/20:5(5Z,8Z,11Z,14Z,17Z)) | ||||||||||||
| Description | LysoPC(0:0/20:5(5Z,8Z,11Z,14Z,17Z)) contains one chain of eicosapentaenoic acid (20:5) at the sn-2. LysoPC(0:0/20:5(5Z,8Z,11Z,14Z,17Z)) is a lysophosphatidylcholine (LysoPC), a type of lysophospholipid (LyP). LysoPCs are monoglycerophospholipids in which a phosphorylcholine group occupies one of the glycerol substitution sites. They contain a single fatty acyl chain at either the sn-1 or sn-2 position and a free hydroxyl group at the other. The most common acyl chains contain 16, 18, or 20 carbons with varying degrees of unsaturation. LysoPCs are formed primarily by hydrolysis of phosphatidylcholine by phospholipase A₂ and can be produced in plasma by LCAT activity. They circulate bound mainly to albumin and act as signaling molecules via lysophospholipid (GPR) receptors. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C28H48NO7P | ||||||||||||
| Average Mass | 541.666 | ||||||||||||
| Monoisotopic Mass | 541.316839888 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | UUZCIIYFIOLREQ-HHHXNRCGSA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | This table shows at most 5 pathways. For the full list of associated pathways: See All Associated Bacterial Pathways
| ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions | |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| External Links | Not Available | ||||||||||||
| References | |||||||||||||
| Synthesis Reference | Not Available | ||||||||||||
| General References | |||||||||||||
